The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of gilteritinib on survival in patients with FLT3-mutated (FLT3mut+) relapsed/refractory (R/R) AML who have common AML co-mutations or a high FLT3-ITD allelic ratio.
 
Mark J. Levis
Consulting or Advisory Role - Agios; Amgen; Astellas Pharma; Daiichi Sankyo; Novartis
Research Funding - Astellas Pharma; Fujifilm; Novartis
 
Alexander E. Perl
Consulting or Advisory Role - Actinium Pharmaceuticals; Arog; Asana biosciences; Astellas Pharma; Daiichi Sankyo; Novartis; Pfizer; Seagen
 
Giovanni Martinelli
Consulting or Advisory Role - ARIAD; Celgene; Pfizer; Roche
Speakers' Bureau - Bristol-Myers Squibb; Novartis
 
Jorge E. Cortes
Consulting or Advisory Role - Amphivena Therapeutics; Astellas Pharma; Bio-Path Holdings, Inc; BiolineRx; Bristol-Myers Squibb; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Pfizer; Takeda
Research Funding - Arog (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celator (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Immunogen (Inst); Merus (Inst); Novartis (Inst); Pfizer (Inst); Sun Pharma (Inst); Takeda (Inst); Tolero Pharmaceuticals (Inst); Trovagene (Inst)
 
Andreas Neubauer
Honoraria - Medupdate
 
Ellin Berman
Consulting or Advisory Role - Astellas Pharma; Takeda
 
Pau Montesinos
Consulting or Advisory Role - Abbvie; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Pfizer; Shire
Speakers' Bureau - Celgene; Daiichi Sankyo; Otsuka
Research Funding - Celgene (Inst); Janssen-Cilag (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen
 
Maria R. Baer
No Relationships to Disclose
 
Richard A. Larson
Consulting or Advisory Role - Abbvie; Agios; Amgen; ARIAD; Astellas Pharma; Boston Biomedical; Celgene; Curis; CVS Caremark; DAVA Pharmaceuticals; ERYTECH Pharma; Novartis; Pfizer
Research Funding - Astellas Pharma (Inst); Celgene (Inst); Daiichi Sankyo (Inst); ERYTECH Pharma (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
 
Wen-Chien Chou
No Relationships to Disclose
 
Hisayuki Yokoyama
No Relationships to Disclose
 
Christian Recher
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Celgene; Daiichi Sankyo; Janssen; Jazz Pharmaceuticals; Macrogenics; Novartis
Research Funding - Agios (Inst); Amgen (Inst); Astellas Pharma (Inst); Celgene (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Jazz Pharmaceuticals (Inst); MaaT Pharma (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Amgen; Celgene; Daiichi Sankyo; Daiichi Sankyo; Incyte; Novartis; Sanofi
 
Sung-Soo Yoon
Consulting or Advisory Role - Abbvie; Celgene; Janssen
Research Funding - Genentech
 
Jason E Hill
Employment - Astellas Pharma
Stock and Other Ownership Interests - Ligacept
Patents, Royalties, Other Intellectual Property - Ligacept
 
Matt Rosales
Employment - Astellas Pharma
 
Charles Liu
Employment - Astellas Pharma
Stock and Other Ownership Interests - Astellas Pharma
 
Erkut Bahceci
Employment - Astellas Pharma
Patents, Royalties, Other Intellectual Property - Astellas Pharma